| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $950.8M | $794.2M | $620.4M |
| YoY Revenue Growth % | +19.7% | +28.0% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $152.9M | $135.6M | $963.0K |
| Operating Margin % | 16.1% | 17.1% | 0.2% |
| Net Income (GAAP) | $140.9M | $204.1M | $2.7M |
| EBITDA (Normalized) | $155.4M | $137.3M | $23.3M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $242.1M | $188.2M | $60.3M |
| Capital Expenditures (CapEx) | $3.2M | $2.0M | $27.9M |
| Free Cash Flow (FCF) | $238.9M | $186.1M | $32.4M |
| FCF Margin % | 25.1% | 23.4% | 5.2% |
| Return on Invested Capital (ROIC %) | 24.1% | 20.4% | 0.0% |
| Cash & Short-Term Equivalents | $107.0M | $42.5M | — |
| Total Debt (Short + Long Term) | $65.9M | $48.3M | $944.8M |
| Total Stockholders' Equity | $542.6M | $519.3M | $1.94B |